Hologic Inc (HOLX)
77.54
-1.64
(-2.07%)
USD |
NASDAQ |
Nov 14, 16:00
77.55
+0.01
(+0.01%)
After-Hours: 20:00
Hologic Research and Development Expense (Quarterly): 67.30M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 67.30M |
| June 30, 2024 | 64.10M |
| March 31, 2024 | 74.60M |
| December 31, 2023 | 66.80M |
| September 30, 2023 | 72.90M |
| June 30, 2023 | 72.60M |
| March 31, 2023 | 74.00M |
| December 31, 2022 | 74.80M |
| September 30, 2022 | 76.00M |
| June 30, 2022 | 65.10M |
| March 31, 2022 | 69.50M |
| December 31, 2021 | 72.80M |
| September 30, 2021 | 76.50M |
| June 30, 2021 | 69.00M |
| March 31, 2021 | 71.50M |
| December 31, 2020 | 59.30M |
| September 30, 2020 | 57.00M |
| June 30, 2020 | 55.10M |
| March 31, 2020 | 49.30M |
| December 31, 2019 | 61.20M |
| September 30, 2019 | 60.40M |
| June 30, 2019 | 61.40M |
| March 31, 2019 | 57.30M |
| December 31, 2018 | 53.20M |
| September 30, 2018 | 52.70M |
| Date | Value |
|---|---|
| June 30, 2018 | 54.40M |
| March 31, 2018 | 56.80M |
| December 31, 2017 | 54.80M |
| September 30, 2017 | 60.50M |
| June 30, 2017 | 62.50M |
| March 31, 2017 | 55.40M |
| December 31, 2016 | 54.40M |
| September 30, 2016 | 62.50M |
| June 30, 2016 | 58.80M |
| March 31, 2016 | 59.10M |
| December 31, 2015 | 51.70M |
| September 30, 2015 | 53.70M |
| June 30, 2015 | 56.00M |
| March 31, 2015 | 53.30M |
| December 31, 2014 | 52.00M |
| September 30, 2014 | 52.10M |
| June 30, 2014 | 52.50M |
| March 31, 2014 | 49.90M |
| December 31, 2013 | 48.70M |
| September 30, 2013 | 48.70M |
| June 30, 2013 | 47.80M |
| March 31, 2013 | 49.62M |
| December 31, 2012 | 51.51M |
| September 30, 2012 | 47.13M |
| June 30, 2012 | 26.23M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
49.30M
Minimum
Mar 2020
76.50M
Maximum
Sep 2021
67.47M
Average
69.25M
Median
Research and Development Expense (Quarterly) Benchmarks
| Nuwellis Inc | 0.558M |
| Varex Imaging Corp | 22.00M |
| Quanterix Corp | 8.104M |
| Bio-Rad Laboratories Inc | 91.00M |
| Revvity Inc | 49.14M |